Home › Prostate Cancer › Arizona › Goodyear
Prostate Cancer clinical trials in Goodyear, AZ
4 studies for Prostate Cancer are looking for participants at sites in and around Goodyear (within about 30 miles). Open a study to see who can join and how to contact the study team.
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RecruitingPhase 3
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Goodyear
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
RecruitingPhase 3
- City of Hope Cancer Center Phoenix, Goodyear
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
RecruitingPhase 2
- Western Regional Medical Center - City of Hope Phoenix Goodyear, Goodyear
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Investigative Site #108, Goodyear
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA60 studies
- St. Louis, MO47 studies
- San Francisco, CA45 studies
- Chicago, IL45 studies
- Seattle, WA44 studies
- Philadelphia, PA44 studies
- Nashville, TN43 studies
- Baltimore, MD42 studies
- Washington, DC38 studies
Other studies in Goodyear
- Non-Small Cell Lung Cancer8 studies
- Metastatic Cancer7 studies
- Breast Cancer6 studies
- Colorectal Cancer5 studies
- Lung Cancer4 studies
- Acute Myeloid Leukemia3 studies
- Pancreatic Cancer3 studies
- Colon Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.